Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2725964
Reference Type
Journal Article
Subtype
Review
Title
Drug-induced gynecomastia
Author(s)
Hugues, FC; Gourlot, C; Le Jeunne, C
Year
2000
Is Peer Reviewed?
Yes
Journal
Annales de Medecine Interne
ISSN:
0003-410X
Volume
151
Issue
1
Page Numbers
10-17
Language
French
PMID
10761558
Web of Science Id
WOS:000086325200002
Abstract
Drugs are a very common cause of gynecomastia and should always be entertained as the possible causal agent of such a condition. This drug side-effect is due to an impaired balance in the serum estrogen/serum androgen ratio, whatever the mechanism, or a rise in prolactin level. Sex hormones, antiandrogens, are frequently involved as well as spironolactone, cimetidine, verapamil and cancer chemotherapy (especially alkylating agents). Diazepam, tricyclic antidepressants, neuroleptics, calcium channel blockers, captopril, digitalis glycosides, omeprazole, some antibiotics and growth hormone are all possibly, but less often, the responsible agent. Criteria of the French method for determining drug causality are discussed.
Keywords
gynecomastia; drug side-effects; drug causality
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity